Eswatini vs Tuvalu: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Eswatini
1.2%
in 2024
Tuvalu
1.1%
in 2024
Eswatini rank
25th
Tuvalu rank
26th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Eswatini
- Tuvalu
How they compare
Eswatini currently reports 1.2% against 1.1% in Tuvalu, a difference of 0.1%.
That makes Eswatini's figure about 1.1 times Tuvalu's.
Across all 10 years both countries report, Eswatini has been ahead every year.
Eswatini ranks 25th and Tuvalu ranks 26th of 215 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eswatini | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 1.3% | 0.2% | Eswatini |
| 2020s | 1.4% | 1.2% | 0.2% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Eswatini or Tuvalu?
- Eswatini, at 1.2% against 1.1% in Tuvalu as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Eswatini and Tuvalu?
- 0.1%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Tuvalu?
- 10 years are reported by both, from 2015 to 2024.
- How do Eswatini and Tuvalu rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Eswatini ranks 25th and Tuvalu ranks 26th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.